Post doc Eyquem Lab UCSF | PhD in Immunology | Cytotoxic lymphocytes
San Francisco, CA
Joined December 2019
- Tweets23
- Following186
- Followers53
- Likes131
Almost a year later and these charts still have me squinting! Quite the adventure, fueled by an amazing amount of energy and talent from our team alongside collaborators. @UCSF @GladstoneInst
We have been asked many times: could in vivo generated CAR T cells work in solid tumors? @PL_Bernard tested it and
YES!
In a uterine Sarcoma model, we show that a single injection of vectors delivering a TRAC-B7H3-CAR can achieve complete responses in our humanized mouse model
After 4 years of thesis work at @crcm_marseille, I'm now a doctor !
A huge thank you to @GeoffGuittard and @NUNESJacques1 for trusting me and teaching me so much.
Thanks to @laliguecancer for the support.
Time to leave the nest now, and what a nest it was!
@TumImmuno_CRCM
Twice in a row.
I’ll probably never get an #ERC grant, but last night, thanks to a fantastic team, I did win something BIG: the legendary blindtest of @crcm_marseille.
Apologies to @TumImmuno_CRCM and @ChrisGinestier. You guys will do better next time 🤪
PL Bernard retweeted
From the September 15 issue—
CD25high Effector Regulatory #TCells Hamper Responses to PD-1 Blockade in Triple-Negative #BreastCancer, by Fattori et al.
bit.ly/454sOvG
@anne_chretien @TumImmuno_CRCM
PL Bernard retweeted
Hello everyone,
We are recruiting a 3-yearpost-doc in immunity and Cancer team in Marseille (France) to work on cell therapy in immuno-oncology. Please contact me if you are interested [email protected] or transfer this offer to find the ideal candidate.
Thanks !
PL Bernard retweeted
Such a plesure to close this tremendous scientific meeting thank you again to the canceropole for this great opportunity.
This Post is from an account that no longer exists. Learn more
PL Bernard retweeted
New #JITC article: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors bit.ly/3BWu5sE @MyeLau_Gorvel @NUNESJacques1 @GeoffGuittard
PL Bernard retweeted
New #JITC review: Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets bit.ly/3Wsr3WC @lavolodon @PL_Bernard @GeoffGuittard @NUNESJacques1
PL Bernard retweeted
Brand new published protocol from @TumImmuno_CRCM !
You'll discover here some secrets of the platform, on how we can generate high dimension data and explore the immune system of cancer patients.
sciencedirect.com/science/ar…
PL Bernard retweeted
Here it is !!!
The very first paper of the #REMAP4Kids team was published today in @eBioMedicine (although we won’t be officially created before Jan 2024).
authors.elsevier.com/sd/arti…
A quick thread to explain what we found.
1/n – at Lyon, France
PL Bernard retweeted
Une étude parue dans la revue "Cell" décrit l’identification d’un mécanisme épigénétique propre aux femmes, qui est impliqué dans le développement de tumeurs agressives.
l.franceculture.fr/fsQ
Thrilled to share my first research paper out in @jitcancer ! Huge thanks to every person involved @EricVivier1 @Dr_Nick_Bikes, and especially to @NUNESJacques1 & @GeoffGuittard
Stay tuned for more exciting data from @TumImmuno_CRCM !
New #JITC article: Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity bit.ly/38C1u0N @PL_Bernard @NUNESJacques1 @GeoffGuittard
And of course, warm thanks to @laliguecancer for supporting my PhD project since 2019.
